SCHEMBL9517224

SCHEMBL9517224

O=C(NS(=O)(=O)c1ccc(Oc2ccc(C(F)(F)F)cc2)cc1)c1ccc(CO)nc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BCL2L1 Q07817 6/20 0.49
▸ MCL1 Q07820 6/20 0.49
▸ P4HTM Q9NXG6 3/20 0.47
▸ ALKBH2 Q6NS38 1/20 0.47
▸ ALKBH5 Q6P6C2 1/20 0.47
▸ ALKBH3 Q96Q83 1/20 0.47
▸ FTO Q9C0B1 1/20 0.47
▸ EGFR P00533 2/20 0.45
▸ MAPK14 Q16539 1/20 0.42
▸ MMP1 P03956 2/20 0.42
▸ MMP2 P08253 1/20 0.42
▸ MMP3 P08254 1/20 0.42
▸ MMP9 P14780 1/20 0.42
▸ MMP8 P22894 1/20 0.42
▸ MMP13 P45452 1/20 0.42
▸ MMP14 P50281 1/20 0.42
▸ PTGS2 P35354 1/20 0.42
▸ SCN3A Q9NY46 1/20 0.42
▸ LIPE Q05469 1/20 0.42
▸ CACNA1H O95180 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9516252 0.90 BCL2L1 (0.50) BCL2L1MCL1P4HTMEGFRMAPK14
SCHEMBL9516981 0.88 BCL2L1 (0.60) BCL2L1MCL1P4HTMEGFRMMP1
SCHEMBL9515597 0.87 P4HTM (0.48) BCL2L1MCL1P4HTMEGFRPTGS2
SCHEMBL9519730 0.87 MCL1 (0.62) BCL2L1MCL1P4HTMEGFRMMP1
SCHEMBL9517198 0.86 EGFR (0.62) BCL2L1MCL1P4HTMEGFRMMP1
SCHEMBL9515436 0.83 BCL2L1 (0.56) BCL2L1MCL1P4HTMEGFRPTGS2
SCHEMBL9516149 0.82 MCL1 (0.53) BCL2L1MCL1P4HTMEGFRMMP1
SCHEMBL9518006 0.82 P4HTM (0.67) P4HTMEGFRMMP1MMP2MMP9
SCHEMBL9519377 0.81 P4HTM (0.45) BCL2L1MCL1P4HTMEGFRPTGS2
SCHEMBL9518008 0.81 P4HTM (0.54) BCL2L1MCL1P4HTMEGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0567997-A1 4- or 5-(sulf)imido- and (sulfon)amidopyridines and their pyridine-N-oxides, process for their preparation and their use as pharmaceutical HOECHST AKTIENGESELLSCHAFT (DE) 1993-11-03 — — EP disclosed
Send feedback